Skip links

Let's Talk About Sex

Other > flibanserin


Monitor sensitive CYP3A4 substrates for effectiveness if coadministered.

Adverse Effects

St John's Wort will decrease the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor CYP3A4 substrates coadministered with stiripentol for increased or decreased effects. CYP3A4 substrates may require fildena pill dosage adjustment.stiripentol will increase the level or effect of flibanserin by affecting hepatic enzyme CYP2C19 metabolism. Consider reducing the dose of CYP2C19 substrates, if adverse reactions are experienced when administered concomitantly with stiripentol.stiripentol, flibanserin. Concomitant use stiripentol with other CNS depressants, including alcohol, may increase the risk of sedation and somnolence.

What should I do if I accidentally use too much Addyi?

sufentanil SLsufentanil SL and flibanserin both increase sedation. Risk for sedation increased if flibanserin is coadministration with other CNS depressants.sufentanil SL, flibanserin. sufentanil SL and flibanserin both increase sedation. sulconazolesulconazole will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. sulconazole will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Learn to recognize the signs of HSDD in your patients.4

tacrolimustacrolimus will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. tacrolimus will increase the level or effect of flibanserin by affecting libido booster for woman hepatic/intestinal enzyme CYP3A4 metabolism. talazoparibflibanserin increases levels of talazoparib by P-glycoprotein (MDR1) efflux transporter. Coadministration with P-gp inhibitors may increase talazoparib exposure. Monitor for increased talazoparib adverse reactions and adjust dose as necessary. tecovirimat will increase the level or effect of flibanserin by affecting hepatic enzyme CYP2C19 metabolism.

  • Reporting of adverse events is encouraged through the FDA MedWatch program.
  • Healthcare providers should report syncope, severe hypotension, or liver injury.
  • Post-marketing surveillance is critical for understanding rare, long-term risks.
  • Drug utilization reviews track prescribing patterns and potential misuse.
  • In case of suspected pregnancy, patients should contact their doctor immediately.
  • Animal studies showed developmental toxicity at doses much higher than human dose.
  • Lactation studies in animals showed excretion in milk; human data are lacking.
  • Decision to breastfeed while on flibanserin requires weighing potential risks.
  • The benefit for an individual patient must justify the potential risk to a fetus/infant.

Monitor for adverse effects if coadministered with sensitive substrates of these enzymes. temsirolimustemsirolimus will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Product Dosage Quantity + Bonus Price
Kamagra100mg120 + 6 Pills330.74€ 314.99€
Cialis Professional40mg270 + 6 Pills898.37€ 855.59€
Cialis Professional40mg90 + 2 Pills348.59€ 331.99€
Levitra Soft Tabs20mg30 + 2 Pills99.17€ 94.45€
Viagra Generic100mg10 Pills28.91€ 27.53€
Viagra Generic25mg180 + 6 Pills154.93€ 147.55€
Cialis Soft Tabs20mg180 + 8 Pills353.17€ 336.35€
Cialis Generic2.5mg360 + 10 Pills260.03€ 247.65€
Kamagra Soft Tabs100mg32 Pills120.11€ 114.39€
Super Kamagra160 mg20 + 4 Pills155.35€ 147.95€
Levitra Professional20mg60 + 2 Pills223.11€ 212.49€
Cialis Generic20mg60 + 6 Pills117.76€ 112.15€
Kamagra Gold50 mg360 + 6 Pills713.95€ 679.95€
Cialis Professional20mg90 + 2 Pills241.49€ 229.99€
Viagra Soft Tabs100mg180 + 10 Pills314.95€ 299.95€
Levitra Professional20mg30 Pills119.12€ 113.45€

temsirolimus will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. teniposideteniposide will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. teniposide will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Issue Description
Efficacy Debate Some experts question the clinical significance of benefits
Side Effect Concerns Risks of hypotension, syncope, and severe allergic reactions
Marketing & Approval Controversies Criticism over FDA approval process and marketing practices
Post-Marketing Surveillance Ongoing monitoring for rare adverse events

testosteronetestosterone will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

  • Global availability varies; approved in the US, Canada, and some other countries.
  • Not approved in the European Union by the EMA as of current knowledge.
  • Different brand names may be used in countries where it is marketed.
  • Importing for personal use from other countries carries risks and is often illegal.
  • Counterfeit versions of the medication are a potential danger.
  • Patients should only obtain it from a certified, licensed pharmacy.
  • Telemedicine may be used for consultations but REMS requirements still apply.
  • The future of flibanserin may involve generic competition reducing cost.
  • Research into its potential effects on other conditions (e.g., depression) is limited.

testosterone will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. testosterone topical will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Before Using

pimozidepimozide will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Increased flibanserin adverse effects may occur if coadministered with multiple weak CYP3A4 inhibitors.flibanserin, pimozide. pimozide will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. pravastatinpravastatin will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. pravastatin will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Label Warnings

prednisoloneprednisolone will increase the level or effect of flibanserin by aldehyde dehydrogenase inhibition. prednisolone will increase the level or effect of flibanserin by aldehyde dehydrogenase inhibition. primaquineprimaquine will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. primaquine will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. primidoneprimidone will decrease the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Patient resources

primidone will decrease the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. progesterone micronizedprogesterone micronized will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. progesterone micronized will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. propofolpropofol will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. propofol will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. tranylcyprominetranylcypromine will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. tranylcypromine will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

  • Potential for negative publicity and stigma surrounding a "pink Viagra."
  • Media coverage often oversimplifies its mechanism and expected results.
  • Patient education is crucial to set realistic expectations about benefits.
  • Support groups and online communities exist for women discussing HSDD treatment.
  • Ongoing research continues to explore other pharmacologic targets for HSDD.
  • Future developments may include new formulations or combination therapies.
  • The approval of flibanserin spurred increased investment in female sexual health.
  • It remains a subject of debate in medical ethics, women's health, and drug regulation.
  • Prescribers should stay updated on post-marketing safety communications.

trazodonetrazodone will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

The #1 Prescribed Treatment for frustrating Low Libido1

quinineflibanserin increases levels of quinine by P-glycoprotein (MDR1) efflux transporter. Increase monitoring of concentrations of drugs transported by P-gp that have a narrow therapeutic index if coadministered with flibanserin.quinine will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. flibanserin increases levels of quinine by P-glycoprotein (MDR1) efflux transporter. rabeprazolerabeprazole will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. rabeprazole will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Less common

ranolazineranolazine premature ejaculation treatment will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ranolazine will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. rifabutin will decrease the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. rifampinrifampin will decrease the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. rifampin will decrease the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Missed Dose

rifapentinerifapentine will decrease the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. rifapentine will decrease the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. risperidonerisperidone will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Increased flibanserin adverse effects may occur if coadministered with multiple weak CYP3A4 inhibitors.flibanserin, risperidone. risperidone will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. trazodone will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. triclabendazoletriclabendazole will increase the level or effect of flibanserin by affecting hepatic enzyme CYP2C19 metabolism. If plasma concentrations of the CYP2C19 substrates are elevated during triclabendazole, recheck plasma concentration of the CYP2C19 substrates after discontinuation of triclabendazole.

Information & Authors

flibanserin increases levels of talazoparib by P-glycoprotein (MDR1) efflux transporter. tamoxifentamoxifen will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. tamoxifen will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. tecovirimattecovirimat will increase the level or effect of flibanserin by affecting hepatic enzyme CYP2C19 metabolism. Monitor for adverse effects if coadministered with sensitive substrates of these enzymes.tecovirimat will decrease the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. triclabendazole will increase the level or effect of flibanserin by affecting hepatic enzyme CYP2C19 metabolism. valproic acidvalproic acid will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

What special precautions should I follow?

rucaparibrucaparib will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. rucaparib will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. scopolamine intranasalscopolamine intranasal and flibanserin both increase sedation. scopolamine intranasal and flibanserin both increase sedation. selegilineselegiline will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Approval Year

selegiline will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. selegiline transdermal will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. sirolimusflibanserin increases levels of sirolimus by P-glycoprotein (MDR1) efflux transporter. Increase monitoring of concentrations of drugs transported by P-gp that have a narrow therapeutic index if coadministered with flibanserin.sirolimus will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. sodium oxybatesodium oxybate and flibanserin both increase sedation.

Dosage forms and strengths (USA)

sodium oxybate and flibanserin both increase sedation. sparsentansparsentan will decrease the level or effect of flibanserin by affecting hepatic enzyme CYP2C19 metabolism. Sparsentan (a CYP2C19 inducer) decreases exposure of CYP2C19 substrates and reduces efficacy related to these substrates. sparsentan will decrease the level or effect of flibanserin by affecting hepatic enzyme CYP2C19 metabolism. St John's WortSt John's Wort will decrease the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism.